Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04801888
What this trial is testing

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

Who this might be right for
COVID-19Influenza
Sinovac Research and Development Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT04551547
What this trial is testing

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 552
Testing effectiveness (Phase 2)Study completedNCT00492648
What this trial is testing

Month 30 & 42 Extension Studies of CRD-004 Primary Study

Who this might be right for
Herpes Zoster
GlaxoSmithKline 34
Large-scale testing (Phase 3)UnknownNCT05969626
What this trial is testing

Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)

Who this might be right for
Rabies
Ningbo Rongan Biological Pharmaceutical Co., Ltd. 2,460
Not applicableWithdrawnNCT02316925
What this trial is testing

GSH Supplementation on Cold/Flu Symptoms in Older Healthy Adults

Who this might be right for
Improvement in Immune Cell Function in Elderly Humans
University of Florida
Early research (Phase 1)Ended earlyNCT02689726
What this trial is testing

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

Who this might be right for
HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Genticel 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07207785
What this trial is testing

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 56
Post-approval studies (Phase 4)Ended earlyNCT01394848
What this trial is testing

Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy

Who this might be right for
Stable Angina
Yonsei University 1
Early research (Phase 1)Active Not RecruitingNCT06539338
What this trial is testing

Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment

Who this might be right for
Lymphomas Non-Hodgkin's B-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Kite, A Gilead Company 10
Large-scale testing (Phase 3)UnknownNCT05599516
What this trial is testing

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Who this might be right for
COVID-19Coronavirus Infections
National Vaccine and Serum Institute, China 16,000
Testing effectiveness (Phase 2)Study completedNCT00541099
What this trial is testing

Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 11
Testing effectiveness (Phase 2)UnknownNCT00678964
What this trial is testing

Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
LungenClinic Grosshansdorf 260
Not applicableEnded earlyNCT05110924
What this trial is testing

RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly

Who this might be right for
Basal Cell CarcinomaElderly
University Hospital, Ghent 9
Testing effectiveness (Phase 2)Study completedNCT03204227
What this trial is testing

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 220
Testing effectiveness (Phase 2)Looking for participantsNCT06646497
What this trial is testing

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Who this might be right for
Aplastic Anemia
Assistance Publique - Hôpitaux de Paris 52
Testing effectiveness (Phase 2)Study completedNCT01528085
What this trial is testing

Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia
Goethe University 79
Post-approval studies (Phase 4)Study completedNCT05547815
What this trial is testing

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

Who this might be right for
RabiesAntibody
Changchun Zhuoyi Biological Co., Ltd 149
Testing effectiveness (Phase 2)UnknownNCT05069129
What this trial is testing

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Who this might be right for
COVID-19 PneumoniaCoronavirus Infections
National Vaccine and Serum Institute, China 1,848
Not applicableStudy completedNCT05089045
What this trial is testing

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 360
Early research (Phase 1)UnknownNCT05552573
What this trial is testing

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 100
Next Page